Mounjaro®
Starting from £179.99/mo
Start journey Learn moreMounjaro can cause skin reactions, though the picture is more nuanced than a simple yes or no. Rashes linked to tirzepatide tend to fall into two distinct categories: localised injection-site reactions and, less commonly, a wider skin response that may signal an allergic reaction. Most are mild and short-lived, but a few warrant prompt medical attention. As a prescription-only medicine reviewed by a GPhC-registered Independent Prescriber before every supply, Mounjaro's safety profile is well-characterised through extensive clinical data. Understanding the difference between the two types of skin reaction, and knowing which signs call for urgent help, is what this page covers.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
A question our prescribers hear most weeks goes roughly like this: "I've got a red mark where I injected — does that mean I'm allergic?" Almost always, the answer is no. Localised injection-site reactions (redness, mild itching, a small raised area, or brief warmth at the site) are listed in the Mounjaro Patient Information Leaflet as common side effects, not signs of allergy. They occur because any subcutaneous injection causes minor local tissue irritation; the body's mast cells respond, histamine is released locally, and you get a short-lived patch of redness.
This type of reaction typically peaks within an hour of injection and clears within a day or two. It tends to be most noticeable in the early weeks of treatment, when the body is still adjusting. Rotating sites across the abdomen, thigh and upper arm with each weekly injection is the single most effective way to reduce frequency. The full tirzepatide treatment overview has more on technique and site rotation.
Allergy is a different mechanism entirely. True hypersensitivity to tirzepatide is uncommon, though it has been reported. Knowing the distinction matters, because the response to each is completely different.
A genuinely allergic skin response to tirzepatide looks different from a small injection-site blush. Signs that something more systemic is happening include urticaria (hives) spreading beyond the injection site, facial or lip swelling, widespread itching across the body, or a rash that keeps expanding rather than settling. These can indicate a hypersensitivity reaction, and some people experience them alongside other symptoms such as shortness of breath, a rapid heartbeat or feeling faint.
Anaphylaxis, the most serious allergic response, is rare but documented in the prescribing literature. The NHS guidance on tirzepatide advises stopping the medicine and seeking emergency medical help if you develop a severe rash, swelling of the face or throat, or difficulty breathing after an injection. Do not take another dose until you have spoken with a doctor or called 111.
For anything less acute (a rash that is spreading but you otherwise feel well) contact your prescriber the same day. You can read more about the broader range of reported Mounjaro side effects to help put any new symptom in context, and the detailed guide to Mounjaro skin rashes covers the visual features clinicians look for. Suspected adverse reactions, including skin reactions, can also be reported directly through the MHRA Yellow Card scheme, which helps build the ongoing safety evidence base for newer medicines like tirzepatide.
Beyond injection-site reactions and allergic responses, some people on Mounjaro report skin changes that aren't straightforwardly either of those things. Rapid weight loss, particularly over several months, can alter skin texture and tone. Reduced calorie intake sometimes affects micronutrient levels, which may in turn affect skin. These effects aren't specific to tirzepatide and are more closely tied to the physiological changes that come with significant weight reduction.
There is also a separate, smaller group of users who develop what looks like eczema or dermatitis in areas unrelated to injection sites. The clinical literature does not yet establish a causal link with tirzepatide specifically, and the NHS tirzepatide medicine page describes injection-site and hypersensitivity reactions as the primary skin-related effects to watch for. If you're noticing skin changes that don't fit either pattern, flagging them with your prescriber is the right move, and our guide to Mounjaro rash can help you describe what you're seeing more precisely before that conversation. Prescribers can also assess whether any other factor, such as a concurrent medicine, is more likely to be responsible. You can explore related skin questions, including whether Mounjaro can cause broader skin rashes, for a closer look at the published evidence.
If you notice redness or itching at an injection site within hours of dosing, the immediate steps are simple: avoid rubbing the area, keep it clean, and apply a cool compress if it's uncomfortable. This type of reaction almost never needs treatment and clears on its own. Switching to a different injection site for your next dose is sensible.
If the rash is spreading, you're itchy all over, or you have any swelling around your face or throat, stop Mounjaro and contact 999 or go to A&E. That's not overcaution; it's the correct clinical response to a possible anaphylactic reaction. For anything in between (a persistent, worsening rash without other symptoms) contact your prescriber the same day. At nume, aftercare is available seven days a week through our support team, so you're not left working out alone whether what you're seeing is serious.
Cost should never be a barrier to raising a safety question. If you're still weighing up whether Mounjaro is the right treatment and want to understand the full picture, our Mounjaro cost and service guide explains what a private prescription with clinical support actually involves. When you're ready to take the next step, you can start your free consultation and have your individual circumstances reviewed by a prescriber, not a form.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.